Updated Jul 17, 2026
Kenkare-Mitra Sara has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $126K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-02 | ALEC | Alector, Inc. | S — Open-market sale | 23.6K | $2.50 | $59K |
| 2025-07-01 | ALEC | Alector, Inc. | A — Grant or award | 54.7K | $0.00 | |
| 2024-12-03 | ALEC | Alector, Inc. | S — Open-market sale | 26.5K | $2.52 | $67K |
| 2024-10-02 | ALEC | Alector, Inc. | A — Grant or award | 300.0K | $0.00 |
Kenkare-Mitra Sara is a corporate insider — currently tracked as Director of Unicycive Therapeutics, Inc. (UNCY). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($126K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kenkare-Mitra Sara profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.